Phathom Pharmaceuticals, Inc. (PHAT)
- Previous Close
8.97 - Open
9.01 - Bid 8.98 x 400
- Ask 9.04 x 400
- Day's Range
8.83 - 9.18 - 52 Week Range
6.07 - 17.02 - Volume
475,081 - Avg. Volume
885,653 - Market Cap (intraday)
527.302M - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-3.93 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
22.71
Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
www.phathompharma.comRecent News: PHAT
Performance Overview: PHAT
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHAT
Valuation Measures
Market Cap
527.30M
Enterprise Value
284.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
677.59
Price/Book (mrq)
--
Enterprise Value/Revenue
417.80
Enterprise Value/EBITDA
-1.79
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-36.14%
Return on Equity (ttm)
--
Revenue (ttm)
682k
Net Income Avi to Common (ttm)
-201.59M
Diluted EPS (ttm)
-3.93
Balance Sheet and Cash Flow
Total Cash (mrq)
381.39M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-90.45M
Research Analysis: PHAT
Company Insights: PHAT
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PHAT
Daily – Vickers Top Buyers & Sellers for 01/26/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/12/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/10/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/13/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.